Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Cann Group ( (AU:CAN) ) just unveiled an update.
Cann Group Limited is hosting an investor update webinar on November 5, 2025, featuring CEO Jenni Pilcher and proposed incoming Chairman Mike Ryan. This event aims to engage shareholders and interested parties, allowing them to submit questions in advance, with a recording available post-session, reflecting the company’s commitment to transparency and stakeholder engagement.
More about Cann Group
Cann Group Limited is an Australian company focused on enhancing patients’ lives by developing, producing, and supplying innovative cannabis medicines. The company operates research facilities and a large-scale cultivation and GMP manufacturing facility in Victoria, offering a range of dried flower, oil products, active pharmaceutical ingredients, and extracts to both domestic and international markets. Cann Group also owns Satipharm, known for its patent-protected capsule technology.
YTD Price Performance: -66.67%
Average Trading Volume: 2,690,359
Technical Sentiment Signal: Sell
Current Market Cap: A$9.15M
See more data about CAN stock on TipRanks’ Stock Analysis page.